BRCA1 andBRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
Authors:
- J T BergthorssonJBJ T Bergthorsson
- B EjlertsenBEB Ejlertsen
- J H OlsenJOJ H Olsen
- A BorgABA Borg
- K V NielsenKNK V Nielsen
- R B BarkardottirRBR B Barkardottir
- S KlausenSKS Klausen
- H T MouridsenHMH T Mouridsen
- K WintherKWK Winther
- K FengerKFK Fenger
- A NiebuhrANA Niebuhr
- T L HarboeTHT L Harboe
Open Access
- 1 June 2001
- journal article
- case report
- Published by BMJ in Journal of Medical Genetics
- Vol. 38 (6) , 361-368
Abstract
INTRODUCTION: A small fraction of breast cancer is the result of germline mutations in theBRCA1 and BRCA2cancer susceptibility genes. Mutation carriers frequently have a positive family history of breast and ovarian cancer, are often diagnosed at a young age, and may have a higher incidence of double or multiple primary breast tumours than breast cancer patients in general. OBJECTIVES: To estimate the prevalence and spectrum of BRCA1 andBRCA2 mutations in young Danish patients affected with bilateral or multifocal breast cancer and to determine the relationship of mutation status to family history of cancer. SUBJECTS: From the files of the Danish Breast Cancer Cooperative Group (DBCG), we selected 119 breast cancer patients diagnosed before the age of 46 years with either bilateral (n=59) or multifocal (n=61) disease. METHODS: DNA from the subjects was screened for BRCA1 andBRCA2 mutations using single strand conformation analysis (SSCA) and the protein truncation test (PTT). Observed and expected cancer incidence in first degree relatives of the patients was estimated using data from the Danish Cancer Registry. RESULTS: Twenty four mutation carriers were identified (20%), of whom 13 had aBRCA1 mutation and 11 carried aBRCA2 mutation. Two mutations inBRCA1 were found repeatedly in the material and accounted for seven of the 24 (29%) mutation carriers. The mutation frequency was about equal in patients with bilateral (22%) and multifocal breast cancer (18%). The incidence of breast and ovarian cancer was greatly increased in first degree relatives ofBRCA1 and BRCA2mutation carriers, but to a much lesser degree in relatives of non-carriers. An increased risk of cancer was also noted in brothers of non-carriers. CONCLUSIONS: A relatively broad spectrum of germline mutations was observed inBRCA1 and BRCA2and most of the mutations are present in other populations. Our results indicate that a diagnosis of bilateral and multifocal breast cancer is predictive of BRCA1 andBRCA2 mutation status, particularly when combined with information on the patients' age at diagnosis and family history of breast/ovarian cancer.Keywords
This publication has 35 references indexed in Scilit:
- BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancerEuropean Journal of Human Genetics, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- The Risk of Cancer Associated with Specific Mutations ofBRCA1andBRCA2among Ashkenazi JewsNew England Journal of Medicine, 1997
- Transcriptional activation functions in BRCA2Nature, 1997
- Identification of a RING protein that can interact in vivo with the BRCA1 gene productNature Genetics, 1996
- A polymorphic stop codon in BRCA2Nature Genetics, 1996
- Human, canine and murine BRCA1 genes: sequence comparison among speciesHuman Molecular Genetics, 1996
- BRCA2 germline mutations in male breast cancer cases and breast cancer familiesNature Genetics, 1996
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995